246 related articles for article (PubMed ID: 32549314)
21. Omega-3 fatty acids eicosapentaenoic acid and docosahexaenoic acid and their mechanisms of action on apolipoprotein B-containing lipoproteins in humans: a review.
Oscarsson J; Hurt-Camejo E
Lipids Health Dis; 2017 Aug; 16(1):149. PubMed ID: 28797250
[TBL] [Abstract][Full Text] [Related]
22. Effects of acute hyperglucagonemia on hepatic and intestinal lipoprotein production and clearance in healthy humans.
Xiao C; Pavlic M; Szeto L; Patterson BW; Lewis GF
Diabetes; 2011 Feb; 60(2):383-90. PubMed ID: 20980459
[TBL] [Abstract][Full Text] [Related]
23. Effects of gastric bypass surgery on postprandial gut and systemic lipid handling.
Jegatheesan P; Seyssel K; Stefanoni N; Rey V; Schneiter P; Giusti V; Lecoultre V; Tappy L
Clin Nutr ESPEN; 2020 Feb; 35():95-102. PubMed ID: 31987128
[TBL] [Abstract][Full Text] [Related]
24. Fasting hepatic de novo lipogenesis is not reliably assessed using circulating fatty acid markers.
Rosqvist F; McNeil CA; Pramfalk C; Parry SA; Low WS; Cornfield T; Fielding BA; Hodson L
Am J Clin Nutr; 2019 Feb; 109(2):260-268. PubMed ID: 30721918
[TBL] [Abstract][Full Text] [Related]
25. Dose Dependent Effects of Fructose and Glucose on de novo Palmitate and Glycerol Synthesis in an Enterocyte Cell Model.
Steenson S; Shojaee-Moradie F; Lovegrove JA; Umpleby AM; Jackson KG; Fielding BA
Mol Nutr Food Res; 2022 Jan; 66(1):e2100456. PubMed ID: 34787358
[TBL] [Abstract][Full Text] [Related]
26. A dual sugar challenge test for lipogenic sensitivity to dietary fructose.
Hudgins LC; Parker TS; Levine DM; Hellerstein MK
J Clin Endocrinol Metab; 2011 Mar; 96(3):861-8. PubMed ID: 21252253
[TBL] [Abstract][Full Text] [Related]
27. Lixisenatide Reduces Chylomicron Triacylglycerol by Increased Clearance.
Whyte MB; Shojaee-Moradie F; Sharaf SE; Jackson NC; Fielding B; Hovorka R; Mendis J; Russell-Jones D; Umpleby AM
J Clin Endocrinol Metab; 2019 Feb; 104(2):359-368. PubMed ID: 30215735
[TBL] [Abstract][Full Text] [Related]
28. Postprandial de novo lipogenesis and metabolic changes induced by a high-carbohydrate, low-fat meal in lean and overweight men.
Marques-Lopes I; Ansorena D; Astiasaran I; Forga L; Martínez JA
Am J Clin Nutr; 2001 Feb; 73(2):253-61. PubMed ID: 11157321
[TBL] [Abstract][Full Text] [Related]
29. Spillover of dietary fatty acids and use of serum nonesterified fatty acids for the synthesis of VLDL-triacylglycerol under two different feeding regimens.
Barrows BR; Timlin MT; Parks EJ
Diabetes; 2005 Sep; 54(9):2668-73. PubMed ID: 16123356
[TBL] [Abstract][Full Text] [Related]
30. Metabolic adaptations to dietary fat malabsorption in chylomicron-deficient mice.
Jung HR; Turner SM; Neese RA; Young SG; Hellerstein MK
Biochem J; 1999 Oct; 343 Pt 2(Pt 2):473-8. PubMed ID: 10510316
[TBL] [Abstract][Full Text] [Related]
31. Hepatic VLDL production in ob/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin.
Wiegman CH; Bandsma RH; Ouwens M; van der Sluijs FH; Havinga R; Boer T; Reijngoud DJ; Romijn JA; Kuipers F
Diabetes; 2003 May; 52(5):1081-9. PubMed ID: 12716736
[TBL] [Abstract][Full Text] [Related]
32. Separation of postprandial lipoproteins: improved purification of chylomicrons using an ApoB100 immunoaffinity method.
Jones GM; Caccavello R; Palii SP; Pullinger CR; Kane JP; Mulligan K; Gugliucci A; Schwarz JM
J Lipid Res; 2020 Mar; 61(3):455-463. PubMed ID: 31888979
[TBL] [Abstract][Full Text] [Related]
33. Fish oil decreases hepatic lipogenic genes in rats fasted and refed on a high fructose diet.
de Castro GS; Cardoso JF; Calder PC; Jordão AA; Vannucchi H
Nutrients; 2015 Mar; 7(3):1644-56. PubMed ID: 25751821
[TBL] [Abstract][Full Text] [Related]
34. Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.
Schwarz JM; Noworolski SM; Wen MJ; Dyachenko A; Prior JL; Weinberg ME; Herraiz LA; Tai VW; Bergeron N; Bersot TP; Rao MN; Schambelan M; Mulligan K
J Clin Endocrinol Metab; 2015 Jun; 100(6):2434-42. PubMed ID: 25825943
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein A-I modulates processes associated with diet-induced nonalcoholic fatty liver disease in mice.
Karavia EA; Papachristou DJ; Liopeta K; Triantaphyllidou IE; Dimitrakopoulos O; Kypreos KE
Mol Med; 2012 Sep; 18(1):901-12. PubMed ID: 22576368
[TBL] [Abstract][Full Text] [Related]
36. Acute-on-chronic effects of fatty acids on intestinal triacylglycerol-rich lipoprotein metabolism.
Black IL; Roche HM; Tully AM; Gibney MJ
Br J Nutr; 2002 Dec; 88(6):661-9. PubMed ID: 12493088
[TBL] [Abstract][Full Text] [Related]
37. Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients.
Lawitz EJ; Li KW; Nyangau E; Field TJ; Chuang JC; Billin A; Wang L; Wang Y; Huss RS; Chung C; Subramanian GM; Myers RP; Hellerstein MK
J Lipid Res; 2022 Sep; 63(9):100250. PubMed ID: 35835205
[TBL] [Abstract][Full Text] [Related]
38. The intracellular triacylglycerol/fatty acid cycle: a comparison of its activity in hepatocytes which secrete exclusively apolipoprotein (apo) B100 very-low-density lipoprotein (VLDL) and in those which secrete predominantly apoB48 VLDL.
Salter AM; Wiggins D; Sessions VA; Gibbons GF
Biochem J; 1998 Jun; 332 ( Pt 3)(Pt 3):667-72. PubMed ID: 9620868
[TBL] [Abstract][Full Text] [Related]
39. Glibenclamide improves postprandial hypertriglyceridaemia in type 2 diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels.
Skrapari I; Perrea D; Ioannidis I; Karabina SA; Elisaf M; Tselepis AD; Karagiannacos P; Katsilambros N
Diabet Med; 2001 Oct; 18(10):781-5. PubMed ID: 11678967
[TBL] [Abstract][Full Text] [Related]
40. Fatty acid and triacylglycerol utilisation by perfused rat spleen: differential metabolic fate and the effect of endotoxin.
Hauton D; Evans RD
Cell Physiol Biochem; 2002; 12(2-3):143-52. PubMed ID: 12077560
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
